Schedule 13G ownership disclosure

Liminal BioSciences Inc.

Security class unavailable · CUSIP: 53272L103

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,029,869
Percent of class
13.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-20-000772
Form type
SC 13G
Filer
Consonance Capital Management LP
CIK
CIK 1544773
Filed
Feb 14, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub